| Field | Row 1 | Row 2 |
|---|---|---|
| adsh | 0001213900-25-046282 | 0001213900-25-031846 |
| cik | 1397795 | 1397795 |
| name | BYRN, INC. | BYRN, INC. |
| sic | 8741 | 8741 |
| countryba | US | US |
| stprba | NV | NV |
| cityba | RENO | RENO |
| zipba | 89501 | 89501 |
| bas1 | 50 WEST LIBERTY STREET, SUITE 880 | 50 WEST LIBERTY STREET, SUITE 880 |
| bas2 | ||
| baph | (646) 768-8417 | (646) 768-8417 |
| countryma | US | US |
| stprma | NV | NV |
| cityma | RENO | RENO |
| zipma | 89501 | 89501 |
| mas1 | 50 WEST LIBERTY STREET, SUITE 880 | 50 WEST LIBERTY STREET, SUITE 880 |
| mas2 | ||
| countryinc | US | US |
| stprinc | NV | NV |
| ein | 204682058 | 204682058 |
| former | BORN, INC. | BORN, INC. |
| changed | 20201201 | 20201201 |
| afs | 4-NON | 4-NON |
| wksi | 0 | 0 |
| fye | 1231 | 1231 |
| form | 10-Q | 10-K |
| period | 20250331 | 20241231 |
| fy | 2025 | 2024 |
| fp | Q1 | FY |
| filed | 20250521 | 20250415 |
| accepted | 2025-05-21 10:41:00.0 | 2025-04-15 12:21:00.0 |
| prevrpt | 0 | 0 |
| detail | 1 | 1 |
| instance | ea0240424-10q_byrninc_htm.xml | ea0231324-10k_byrninc_htm.xml |
| nciks | 1 | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-031846 | 20231231 | Additional Paid In Capital | 117017022.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-031846 | 20110731 | Common Stock Shares Authorized | 900000000.0000 | shares | 0 | us-gaap/2024 | Range= Minimum; | ||
| 0001213900-25-031846 | 20201130 | Common Stock Shares Authorized | 2500000000.0000 | shares | 0 | us-gaap/2024 | Range= Minimum; | ||
| 0001213900-25-031846 | 20231231 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Net Cash Provided By Used In Operating Activities | -46075.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Preferred Stock Value | 10000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20231231 | Retained Earnings Accumulated Deficit | -117477124.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Retained Earnings Accumulated Deficit | -117522111.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20231231 | Revenues | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031846 | 20241231 | Administrative Expensesrelated Party | 44987.0000 | USD | 4 | 0001213900-25-031846 | |||
| 0001213900-25-031846 | 20231231 | Liabilities Current | 30117.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Liabilities Current | 56586.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20231231 | Nonoperating Income Expense | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031846 | 20231231 | Preferred Stock Shares Issued | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Preferred Stock Shares Outstanding | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Revenues | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-046282 | 20250331 | Proceeds From Related Party Debt | 15297.0000 | USD | 1 | us-gaap/2025 | Related Party Transactions By Related Party= Mr Lazar; | ||
| 0001213900-25-031846 | 20241231 | Additional Paid In Capital | 117035540.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Adjustments To Additional Paid In Capital Retirementof Related Party Debt | 18518.0000 | USD | 4 | 0001213900-25-031846 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-031846 | 20110731 | Common Stock Shares Authorized | 2510000000.0000 | shares | 0 | us-gaap/2024 | Range= Maximum; | ||
| 0001213900-25-031846 | 20231231 | Common Stock Shares Issued | 419984423.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Common Stock Shares Issued | 419984423.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20210228 | Common Stock Shares Outstanding | 409353807.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031846 | 20231231 | Common Stock Shares Outstanding | 419984423.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Common Stock Shares Outstanding | 419984423.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20231231 | Liabilities And Stockholders Equity | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-031846 | 20241231 | Liabilities And Stockholders Equity | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-031846 | 20241231 | Net Cash Provided By Used In Financing Activities | 46075.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20231231 | Net Cash Provided By Used In Operating Activities | -15677.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20231231 | Operating Income Loss | -21221.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20221231 | Stockholders Equity | -8896.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Stockholders Equity | -56586.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20231231 | Accounts Payable Current | 14440.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Adjustments To Additional Paid In Capital Retirementof Related Party Debt | 18518.0000 | USD | 4 | 0001213900-25-031846 | |||
| 0001213900-25-031846 | 20210228 | Common Stock Shares Issued | 409353807.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031846 | 20231231 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -21221.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20231231 | Liabilities | 30117.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20231231 | Net Cash Provided By Used In Financing Activities | 15677.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20231231 | Net Income Loss | -21221.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Net Income Loss | -44987.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Nonoperating Income Expense | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031846 | 20241231 | Operating Expenses | 44987.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20200831 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | Title Of Individual= Mr Lazar; | ||
| 0001213900-25-031846 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20231231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20200331 | Preferred Stock Shares Issued | 10000000.0000 | shares | 0 | us-gaap/2024 | Title Of Individual= Mr Lazar; | ||
| 0001213900-25-031846 | 20231231 | Proceeds From Related Party Debt | 15677.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Proceeds From Related Party Debt | 46075.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20221231 | Stockholders Equity | 117017022.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-031846 | 20221231 | Stockholders Equity | 10000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001213900-25-031846 | 20231231 | Stockholders Equity | 117017022.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-031846 | 20231231 | Stockholders Equity | -117477124.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001213900-25-031846 | 20241231 | Stockholders Equity | -117522111.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001213900-25-046282 | 20240331 | Shares Outstanding | 419984423.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-046282 | 20250331 | Stockholders Equity | 10000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001213900-25-046282 | 20250331 | Assets | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-046282 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-046282 | 20110731 | Common Stock Shares Authorized | 2510000000.0000 | shares | 0 | us-gaap/2025 | Range= Maximum; | ||
| 0001213900-25-046282 | 20240331 | Net Cash Provided By Used In Investing Activities | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-046282 | 20250331 | Net Cash Provided By Used In Operating Activities | -15297.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Net Income Loss | -16410.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-046282 | 20241231 | Notes Payable Current | 43234.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Related Party; | ||
| 0001213900-25-046282 | 20250331 | Preferred Stock Shares Outstanding | 10000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Series A Preferred Stock; | ||
| 0001213900-25-046282 | 20241231 | Shares Outstanding | 419984423.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-046282 | 20231231 | Stockholders Equity | 117017022.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-046282 | 20240331 | Stockholders Equity | 419985.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-046282 | 20241231 | Stockholders Equity | -56586.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Stockholders Equity | -117538521.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-046282 | 20250331 | Operating Expenses | 16410.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Additional Paid In Capital | 117035540.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-046282 | 20201130 | Common Stock Shares Authorized | 2500000000.0000 | shares | 0 | us-gaap/2025 | Range= Minimum; | ||
| 0001213900-25-046282 | 20210228 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-046282 | 20241231 | Common Stock Shares Issued | 419984423.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20241231 | Common Stock Value | 419985.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Liabilities Current | 72996.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20240331 | Net Income Loss | -1817.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Notes Payable Current | 58531.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Mr Lazar; | ||
| 0001213900-25-046282 | 20241231 | Preferred Stock Value | 10000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Proceeds From Related Party Debt | 15297.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20240331 | Revenues | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-046282 | 20240331 | Stockholders Equity | 117017022.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-046282 | 20250331 | Accounts Payable Current | 14465.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-046282 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20110731 | Common Stock Shares Authorized | 2500000000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-046282 | 20241231 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Common Stock Shares Outstanding | 419984423.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Common Stock Value | 419985.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20240331 | Earnings Per Share Basic | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20240331 | Income Tax Expense Benefit | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-046282 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 1113.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Nonoperating Income Expense | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-046282 | 20240331 | Operating Income Loss | -1817.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20241231 | Preferred Stock Shares Outstanding | 10000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20241231 | Stockholders Equity | 117035540.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-046282 | 20250331 | Stockholders Equity | -72996.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 419763612.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20240331 | Administrative Expensesrelated Party | 1817.0000 | USD | 1 | 0001213900-25-046282 | |||
| 0001213900-25-046282 | 20110731 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-046282 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20210228 | Common Stock Shares Outstanding | 409353807.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-046282 | 20241231 | Common Stock Shares Outstanding | 419984423.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20240331 | Earnings Per Share Diluted | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -16410.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20241231 | Liabilities And Stockholders Equity | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-046282 | 20240331 | Net Cash Provided By Used In Financing Activities | 629.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Preferred Stock Shares Issued | 10000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Preferred Stock Shares Outstanding | 10000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20231231 | Shares Outstanding | 419984423.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-046282 | 20250331 | Shares Outstanding | 10000000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001213900-25-046282 | 20231231 | Stockholders Equity | 419985.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-046282 | 20241231 | Stockholders Equity | 419985.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-046282 | 20250331 | Stockholders Equity | 117035540.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-046282 | 20241231 | Accounts Payable Current | 13352.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Administrative Expensesrelated Party | 16410.0000 | USD | 1 | 0001213900-25-046282 | |||
| 0001213900-25-046282 | 20241231 | Assets | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-046282 | 20110731 | Common Stock Shares Authorized | 900000000.0000 | shares | 0 | us-gaap/2025 | Range= Minimum; | ||
| 0001213900-25-046282 | 20210228 | Common Stock Shares Issued | 409353807.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-046282 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 1188.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20241231 | Liabilities | 56586.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20240331 | Net Cash Provided By Used In Operating Activities | -629.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Net Income Loss | -16410.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20200831 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Class Of Stock= Series A Preferred Stock; | ||
| 0001213900-25-046282 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20240331 | Proceeds From Related Party Debt | 629.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20241231 | Retained Earnings Accumulated Deficit | -117522111.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Revenues | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-046282 | 20240331 | Stockholders Equity | -117478941.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-046282 | 20241231 | Stockholders Equity | -117522111.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-046282 | 20241231 | Additional Paid In Capital | 117035540.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-046282 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-046282 | 20250331 | Common Stock Shares Issued | 419984423.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Earnings Per Share Basic | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Income Tax Expense Benefit | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-046282 | 20250331 | Liabilities | 72996.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20241231 | Liabilities Current | 56586.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20240331 | Nonoperating Income Expense | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-046282 | 20240331 | Operating Expenses | 1817.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20241231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Preferred Stock Value | 10000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20231231 | Stockholders Equity | -30117.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20240331 | Stockholders Equity | -31934.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 419763612.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Liabilities And Stockholders Equity | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-046282 | 20250331 | Net Cash Provided By Used In Investing Activities | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-046282 | 20250331 | Notes Payable Current | 58531.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Related Party; | ||
| 0001213900-25-046282 | 20250331 | Operating Income Loss | -16410.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20200930 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Class Of Stock= Series A Convertible Preferred Stock; | ||
| 0001213900-25-046282 | 20200331 | Preferred Stock Shares Issued | 10000000.0000 | shares | 0 | us-gaap/2025 | Title Of Individual= Mr Lazar; | ||
| 0001213900-25-046282 | 20250331 | Shares Outstanding | 419984423.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-046282 | 20231231 | Stockholders Equity | -117477124.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-046282 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-046282 | 20201130 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2025 | Range= Maximum; | ||
| 0001213900-25-046282 | 20250331 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Earnings Per Share Diluted | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -1817.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20250331 | Net Cash Provided By Used In Financing Activities | 15297.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20240331 | Net Income Loss | -1817.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-046282 | 20110731 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001213900-25-046282 | 20250331 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20241231 | Preferred Stock Shares Issued | 10000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20241231 | Preferred Stock Shares Outstanding | 10000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Series A Preferred Stock; | ||
| 0001213900-25-046282 | 20250331 | Retained Earnings Accumulated Deficit | -117538521.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-046282 | 20231231 | Shares Outstanding | 10000000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001213900-25-046282 | 20240331 | Shares Outstanding | 10000000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001213900-25-046282 | 20241231 | Shares Outstanding | 10000000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001213900-25-046282 | 20231231 | Stockholders Equity | 10000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001213900-25-046282 | 20240331 | Stockholders Equity | 10000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001213900-25-046282 | 20241231 | Stockholders Equity | 10000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Preferred Stock; | ||
| 0001213900-25-046282 | 20250331 | Stockholders Equity | 419985.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-031846 | 20231231 | Assets | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-031846 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031846 | 20231231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20201130 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2024 | Range= Maximum; | ||
| 0001213900-25-031846 | 20210228 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031846 | 20241231 | Common Stock Value | 419985.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20231231 | Earnings Per Share Basic | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Earnings Per Share Basic | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -44987.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20231231 | Net Income Loss | -21221.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001213900-25-031846 | 20241231 | Net Income Loss | -44987.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001213900-25-031846 | 20200930 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Convertible Preferred Stock; | ||
| 0001213900-25-031846 | 20110731 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001213900-25-031846 | 20241231 | Preferred Stock Shares Issued | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20231231 | Preferred Stock Shares Outstanding | 10000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001213900-25-031846 | 20221231 | Shares Outstanding | 419763612.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031846 | 20231231 | Shares Outstanding | 419763612.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031846 | 20241231 | Shares Outstanding | 419763612.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031846 | 20241231 | Shares Outstanding | 10000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001213900-25-031846 | 20231231 | Stockholders Equity | 10000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001213900-25-031846 | 20241231 | Stockholders Equity | 117035540.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-031846 | 20231231 | Earnings Per Share Diluted | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Earnings Per Share Diluted | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Forgiveness Of Related Party Loan | 18518.0000 | USD | 4 | 0001213900-25-031846 | |||
| 0001213900-25-031846 | 20231231 | Income Tax Expense Benefit | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031846 | 20241231 | Income Tax Expense Benefit | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031846 | 20241231 | Increase Decrease In Accounts Payable And Accrued Liabilities | -1088.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Liabilities | 56586.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Notes Payable Current | 43234.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0001213900-25-031846 | 20231231 | Operating Expenses | 21221.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Operating Income Loss | -44987.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20221231 | Stockholders Equity | 419985.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031846 | 20231231 | Stockholders Equity | 419985.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031846 | 20241231 | Stockholders Equity | 419985.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031846 | 20231231 | Weighted Average Number Of Shares Outstanding Basic | 419763612.0000 | shares | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Weighted Average Number Of Shares Outstanding Basic | 419763612.0000 | shares | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20231231 | Administrative Expensesrelated Party | 21221.0000 | USD | 4 | 0001213900-25-031846 | |||
| 0001213900-25-031846 | 20221231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-031846 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-031846 | 20110731 | Common Stock Shares Authorized | 2500000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031846 | 20241231 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20231231 | Forgiveness Of Related Party Loan | USD | 4 | 0001213900-25-031846 | ||||
| 0001213900-25-031846 | 20231231 | Increase Decrease In Accounts Payable And Accrued Liabilities | 5544.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20231231 | Notes Payable Current | 15677.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0001213900-25-031846 | 20231231 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20231231 | Preferred Stock Value | 10000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20221231 | Stockholders Equity | -117455902.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001213900-25-031846 | 20231231 | Stockholders Equity | -30117.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Accounts Payable Current | 13352.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Adjustments To Additional Paid In Capital Retirementof Related Party Debt | 18518.0000 | USD | 4 | 0001213900-25-031846 | Related Party Transactions By Related Party= Mr Lazar; | ||
| 0001213900-25-031846 | 20241231 | Assets | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-031846 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031846 | 20231231 | Common Stock Value | 419985.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20231231 | Preferred Stock Shares Outstanding | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031846 | 20241231 | Preferred Stock Shares Outstanding | 10000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001213900-25-031846 | 20221231 | Shares Outstanding | 10000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001213900-25-031846 | 20231231 | Shares Outstanding | 10000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001213900-25-031846 | 20241231 | Stockholders Equity | 10000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets. |
| Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Earnings Per Share Diluted | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation | Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Additional Paid In Capital | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Administrative Expensesrelated Party | 0001213900-25-031846 | 1 | 0 | monetary | D | D | Administrative Expensesrelated Party | Amount of general and administrative expense classified as other. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Operating Expenses | us-gaap/2025 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Proceeds From Related Party Debt | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Related Party Debt | The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. |
| Adjustments To Additional Paid In Capital Retirementof Related Party Debt | 0001213900-25-031846 | 1 | 0 | monetary | D | C | Adjustments To Additional Paid In Capital Retirementof Related Party Debt | Retirement of related party debt. |
| Administrative Expensesrelated Party | 0001213900-25-046282 | 1 | 0 | monetary | D | D | Administrative Expensesrelated Party | Amount of general and administrative expense classified as other. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Operating Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Preferred Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Notes Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. |
| Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Nonoperating Income Expense | us-gaap/2025 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Notes Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Revenues | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
| Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Income Tax Expense Benefit | us-gaap/2025 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Revenues | us-gaap/2025 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Liabilities | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Preferred Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Proceeds From Related Party Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Related Party Debt | The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. |
| Accounts Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Preferred Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Forgiveness Of Related Party Loan | 0001213900-25-031846 | 1 | 0 | monetary | D | C | Forgiveness Of Related Party Loan | The amount of forgiveness of related party loan. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
| Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-031846 | 3 | 7 | BS | 0 | H | Assets | us-gaap/2024 | Total Assets | 0 |
| 0001213900-25-031846 | 3 | 9 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001213900-25-031846 | 3 | 10 | BS | 0 | H | Notes Payable Current | us-gaap/2024 | Related party payables | 0 |
| 0001213900-25-031846 | 3 | 11 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Current liabilities | 0 |
| 0001213900-25-031846 | 3 | 12 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001213900-25-031846 | 3 | 14 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, par value $.001, 10,000,000 shares authorized, 10,000,000 issued and outstanding as of December 31, 2024 and December 31, 2023 respectively | 0 |
| 0001213900-25-031846 | 3 | 15 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, Par Value $.001, 500,000,000 shares authorized, 419,984,423 and 419,984,423 issued and outstanding of shares as of December 31, 2024 and December 31, 2023, respectively | 0 |
| 0001213900-25-031846 | 3 | 16 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid in capital | 0 |
| 0001213900-25-031846 | 3 | 17 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001213900-25-031846 | 3 | 18 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total Stockholders (Deficit) | 0 |
| 0001213900-25-031846 | 3 | 19 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total Liabilities and Stockholders Deficit | 0 |
| 0001213900-25-031846 | 4 | 1 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value (in Dollars per share) | 0 |
| 0001213900-25-031846 | 4 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
| 0001213900-25-031846 | 4 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
| 0001213900-25-031846 | 4 | 4 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
| 0001213900-25-031846 | 4 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value (in Dollars per share) | 0 |
| 0001213900-25-031846 | 4 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001213900-25-031846 | 4 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001213900-25-031846 | 4 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001213900-25-031846 | 5 | 1 | IS | 0 | H | Revenues | us-gaap/2024 | Revenue | 0 |
| 0001213900-25-031846 | 5 | 3 | IS | 0 | H | Administrative Expensesrelated Party | 0001213900-25-031846 | Administrative expenses -related party | 0 |
| 0001213900-25-031846 | 5 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001213900-25-031846 | 5 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | (Loss) from operations | 0 |
| 0001213900-25-031846 | 5 | 7 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Other (expense) net | 0 |
| 0001213900-25-031846 | 5 | 8 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss before provision for income taxes | 0 |
| 0001213900-25-031846 | 5 | 9 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Provision for income taxes | 1 |
| 0001213900-25-031846 | 5 | 10 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net Loss | 0 |
| 0001213900-25-031846 | 5 | 11 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic (loss) per common share (in Dollars per share) | 0 |
| 0001213900-25-031846 | 5 | 12 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted (loss) per common share (in Dollars per share) | 0 |
| 0001213900-25-031846 | 5 | 13 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average number of shares outstanding (in Shares) | 0 |
| 0001213900-25-031846 | 6 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001213900-25-031846 | 6 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance (in Shares) | 0 |
| 0001213900-25-031846 | 6 | 11 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001213900-25-031846 | 6 | 12 | EQ | 0 | H | Adjustments To Additional Paid In Capital Retirementof Related Party Debt | 0001213900-25-031846 | Retirement of related party debt | 0 |
| 0001213900-25-031846 | 6 | 13 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001213900-25-031846 | 6 | 14 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance (in Shares) | 0 |
| 0001213900-25-031846 | 7 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net (loss) | 0 |
| 0001213900-25-031846 | 7 | 4 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
| 0001213900-25-031846 | 7 | 5 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash (used in) operating activities | 0 |
| 0001213900-25-031846 | 7 | 7 | CF | 0 | H | Proceeds From Related Party Debt | us-gaap/2024 | Proceeds from related party loans | 0 |
| 0001213900-25-031846 | 7 | 8 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0001213900-25-031846 | 7 | 9 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net Increase (Decrease) In Cash | 0 |
| 0001213900-25-031846 | 7 | 10 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash At The Beginning Of The Period | 0 |
| 0001213900-25-031846 | 7 | 11 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash At The End Of The Period | 0 |
| 0001213900-25-031846 | 7 | 13 | CF | 0 | H | Forgiveness Of Related Party Loan | 0001213900-25-031846 | Forgiveness of related party loan | 0 |
| 0001213900-25-046282 | 2 | 6 | BS | 0 | H | Assets | us-gaap/2025 | Total Assets | 0 |
| 0001213900-25-046282 | 2 | 8 | BS | 0 | H | Accounts Payable Current | us-gaap/2025 | Accounts payable | 0 |
| 0001213900-25-046282 | 2 | 9 | BS | 0 | H | Notes Payable Current | us-gaap/2025 | Related party payables | 0 |
| 0001213900-25-046282 | 2 | 10 | BS | 0 | H | Liabilities Current | us-gaap/2025 | Current liabilities | 0 |
| 0001213900-25-046282 | 2 | 11 | BS | 0 | H | Liabilities | us-gaap/2025 | Total liabilities | 0 |
| 0001213900-25-046282 | 2 | 13 | BS | 0 | H | Preferred Stock Value | us-gaap/2025 | Preferred stock, par value $0.001, 10,000,000 shares authorized, 10,000,000 issued and outstanding as of March 31, 2025 and December 31, 2024 respectively | 0 |
| 0001213900-25-046282 | 2 | 14 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Common stock, Par Value $0.001, 500,000,000 shares authorized, 419,984,423 issued and outstanding of shares as of March 31, 2025 and December 31, 2024 | 0 |
| 0001213900-25-046282 | 2 | 15 | BS | 0 | H | Additional Paid In Capital | us-gaap/2025 | Additional paid in capital | 0 |
| 0001213900-25-046282 | 2 | 16 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Accumulated deficit | 0 |
| 0001213900-25-046282 | 2 | 17 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | Total Stockholders (Deficit) | 0 |
| 0001213900-25-046282 | 2 | 18 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | Total Liabilities and Stockholders Deficit | 0 |
| 0001213900-25-046282 | 3 | 1 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | Preferred stock, par value (in Dollars per share) | 0 |
| 0001213900-25-046282 | 3 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2025 | Preferred stock, shares authorized | 0 |
| 0001213900-25-046282 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2025 | Preferred stock, shares issued | 0 |
| 0001213900-25-046282 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2025 | Preferred stock, shares outstanding | 0 |
| 0001213900-25-046282 | 3 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Common stock, par value (in Dollars per share) | 0 |
| 0001213900-25-046282 | 3 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Common stock, shares authorized | 0 |
| 0001213900-25-046282 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Common stock, shares issued | 0 |
| 0001213900-25-046282 | 3 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Common stock, shares outstanding | 0 |
| 0001213900-25-046282 | 4 | 1 | IS | 0 | H | Revenues | us-gaap/2025 | Revenue | 0 |
| 0001213900-25-046282 | 4 | 3 | IS | 0 | H | Administrative Expensesrelated Party | 0001213900-25-046282 | Administrative expenses -related party | 0 |
| 0001213900-25-046282 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2025 | Total operating expenses | 0 |
| 0001213900-25-046282 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2025 | (Loss) from operations | 0 |
| 0001213900-25-046282 | 4 | 6 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2025 | Other (expense) net | 0 |
| 0001213900-25-046282 | 4 | 7 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | Income (loss) before provision for income taxes | 0 |
| 0001213900-25-046282 | 4 | 8 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2025 | Provision for income taxes | 1 |
| 0001213900-25-046282 | 4 | 9 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net Loss | 0 |
| 0001213900-25-046282 | 4 | 10 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2025 | Basic (loss) per common share (in Dollars per share) | 0 |
| 0001213900-25-046282 | 4 | 11 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2025 | Diluted (loss) per common share (in Dollars per share) | 0 |
| 0001213900-25-046282 | 4 | 12 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | Weighted average number of shares outstanding (in Shares) | 0 |
| 0001213900-25-046282 | 5 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001213900-25-046282 | 5 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in Shares) | 0 |
| 0001213900-25-046282 | 5 | 11 | EQ | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001213900-25-046282 | 5 | 12 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001213900-25-046282 | 5 | 13 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in Shares) | 0 |
| 0001213900-25-046282 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2025 | Net (loss) | 0 |
| 0001213900-25-046282 | 6 | 4 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2025 | Accounts payable and accrued expenses | 0 |
| 0001213900-25-046282 | 6 | 5 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | Net cash (used in) operating activities | 0 |
| 0001213900-25-046282 | 6 | 7 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2025 | Net cash provided by (used in) investing activities | 0 |
| 0001213900-25-046282 | 6 | 9 | CF | 0 | H | Proceeds From Related Party Debt | us-gaap/2025 | Proceeds from related party loans | 0 |
| 0001213900-25-046282 | 6 | 10 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2025 | Net cash provided by financing activities | 0 |
| 0001213900-25-046282 | 6 | 11 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2025 | Net Increase (Decrease) In Cash | 0 |
| 0001213900-25-046282 | 6 | 12 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash At The Beginning Of The Period | 0 |
| 0001213900-25-046282 | 6 | 13 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash At The End Of The Period | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |